Law360, New York (February 05, 2013, 4:58 PM ET) -- A bipartisan pair of senators said Tuesday they have introduced legislation meant to block so-called pay-for-delay agreements, the potentially anti-competitive pharmaceutical patent settlements that keep generic drugs off the market.
Sens. Amy Klobuchar, D-Minn., and Chuck Grassley, R-Iowa, proposed a bill that would crack down on pay-for-delay deals, in which a brand-name pharmaceutical company pays to keep a generic-drug manufacturer from bringing its drug to market for a certain period of time, according to a statement issued Tuesday by Klobuchar's office. Sens. Al Franken, D-Minn., Dick...
Sens. Introduce Bill To Ban Pay-For-Delay Deals
To view the full article, take a free trial now.
